Data as of Aug 25, 2026 · Based on 290 AI responses from ChatGPT Search and Google AI Mode · See how Parse measures this
The best platform for tracking heart failure depends on the patient's specific needs. For patients with implanted devices like pacemakers or ICDs, Medtronic CareLink is the industry standard. For general home management of weight and blood pressure, platforms like
HealthSnap and
CareSimple are favored for their cellular-enabled, easy-to-use devices that do not require patients to have Wi-Fi or smartphones.
Brands AI recommends here
Named in 49% of answers
Best for general home monitoring, particularly for seniors. It uses cellular-connected devices (scales and blood pressure monitors) that require no setup, making it ideal for patients without reliable Wi-Fi or smartphone skills.
Named in 48% of answers
Named in 27% of answers
Named in 25% of answers
If your goal is **chronic heart failure patients monitored at home**, my top overall choice today would be **Cadence**—particularly for a health system or cardiology organization that wants **RPM plus an actual clinical-care layer**, rather than simply a device/data platform. ### My ranking Platform | Best for | HF…
If your goal is chronic heart failure patients monitored at home, my top overall choice today would be Cadence—particularly for a health system or cardiology organization that wants RPM plus an actual clinical-care layer, rather than simply a device/data platform.
| Platform | Best for | HF fit | Key advantage |
|---|---|---|---|
| Cadence | Comprehensive HF programs | ⭐⭐⭐⭐⭐ | RPM + clinician-led care + medication/GDMT optimization |
| Biofourmis | High-acuity/advanced monitoring | ⭐⭐⭐⭐⭐ | Continuous biosensors + AI/digital biomarkers |
| Current Health | Health systems building Hospital-at-Home/RPM | ⭐⭐⭐⭐½ | Flexible, device-agnostic platform |
| Standalone RPM vendors | Practices wanting basic billing/monitoring | ⭐⭐⭐ | Lower complexity/cost, but less clinical depth |
Cadence combines connected weight, BP and other vital-sign monitoring with a clinical team that reviews the data and intervenes. That's important in HF: simply collecting daily weights isn't necessarily enough. The JACC scientific statement notes that weight changes can be a relatively insensitive warning signal for worsening HF.
More importantly, Cadence has published HF-specific outcomes. In one analysis of HFrEF patients, patients receiving its comprehensive RPM program increased the proportion receiving all four guideline-directed medication classes from 7% to 23%, while systolic/diastolic BP and weight also improved. Cadence Providence Its newer 2025 outcomes report describes a 3× increase in GDMT among 2,697 HFrEF patients.
That's a meaningful distinction: the best HF RPM program isn't necessarily the platform with the most sensors; it's the one that turns physiologic changes into timely clinical action.
Biofourmis would be my choice if you're dealing with higher-acuity patients or want continuous physiologic monitoring. Its platform can combine medical-grade devices and biosensors, including continuous measurements, with AI-based algorithms that establish individualized baselines and identify clinically significant deviations.
Its HF technology has also been used with wearable monitoring of heart rate, respiratory rate, oxygen saturation, activity and other physiologic parameters.
Don't select an RPM vendor solely on claimed hospitalization reductions. A 2026 systematic review of 65 randomized trials (~23,000 patients) found that RPM overall was associated with lower mortality and HF hospitalization, but the evidence varied by setting and modality; importantly, it did not find a statistically significant difference between RPM modalities.
So I'd evaluate vendors on:
CMS specifically requires connected medical devices that digitally transmit physiologic data and describes BP cuffs, scales and pulse oximeters as examples; RPM also involves both device/data collection and clinician treatment/management.
Bottom line: For a U.S. health system asking me to pick one platform for a chronic HF-at-home program, I'd start with Cadence. For more continuous/high-acuity physiologic monitoring, I'd put Biofourmis at the top of the shortlist.
If you're evaluating this for a hospital, cardiology practice, ACO, or home-health program, I can also give you a side-by-side 2026 comparison of Cadence vs Biofourmis vs Current Health vs Health Recovery Solutions, including devices, EHR integration, clinical staffing, CMS reimbursement, published HF outcomes, and likely pricing model.
That's a meaningful distinction: the best HF RPM program isn't necessarily the platform with the most sensors; it's the one that turns physiologic changes into timely clinical action.
Biofourmis would be my choice if you're dealing with higher-acuity patients or want continuous physiologic monitoring. Its platform can combine medical-grade devices and biosensors, including continuous measurements, with AI-based algorithms that establish individualized baselines and identify clinically significant deviations.
Its HF technology has also been used with wearable monitoring of heart rate, respiratory rate, oxygen saturation, activity and other physiologic parameters.
Don't select an RPM vendor solely on claimed hospitalization reductions. A 2026 systematic review of 65 randomized trials (~23,000 patients) found that RPM overall was associated with lower mortality and HF hospitalization, but the evidence varied by setting and modality; importantly, it did not find a statistically significant difference between RPM modalities.
So I'd evaluate vendors on:
There is no single "best" remote patient monitoring (RPM) platform for chronic heart failure (CHF) because the ideal choice depends on whether your practice needs non-invasive daily tracking (weight, blood pressure), implantable pulmonary artery pressure monitoring, or fully outsourced clinical…
There is no single "best" remote patient monitoring (RPM) platform for chronic heart failure (CHF) because the ideal choice depends on whether your practice needs non-invasive daily tracking (weight, blood pressure), implantable pulmonary artery pressure monitoring, or fully outsourced clinical triage.
For tracking heart failure at home—where catching early fluid retention and sudden weight spikes is critical—the top-performing RPM platforms are categorized below by their primary strengths:
Key Features to Look For in CHF Monitoring
To help narrow down the best fit, could you tell me:
When tracking chronic heart failure (CHF) at home, the "best" remote patient monitoring (RPM) platform depends on whether you need invasive hemodynamic tracking (like pulmonary artery pressure) or comprehensive non-invasive multi-vital tracking (weight, blood pressure, ECG, and activity) paired with an intuitive…
When tracking chronic heart failure (CHF) at home, the "best" remote patient monitoring (RPM) platform depends on whether you need invasive hemodynamic tracking (like pulmonary artery pressure) or comprehensive non-invasive multi-vital tracking (weight, blood pressure, ECG, and activity) paired with an intuitive clinical dashboard.
Heart failure management relies heavily on catching early fluid retention and decompensation before it triggers hospitalization. Top-tier platforms stand out for specific clinical workflows:
Key Capabilities to Look For in CHF Tracking:
To help narrow down the ideal platform, could you tell me:
There is no single “best” remote patient monitoring (RPM) platform for chronic heart failure (HF) patients at home—the right choice depends on whether you are a health system, cardiology practice, HF clinic, or home-care organization, and whether you need simple vital-sign tracking or advanced congestion prediction.…
There is no single “best” remote patient monitoring (RPM) platform for chronic heart failure (HF) patients at home—the right choice depends on whether you are a health system, cardiology practice, HF clinic, or home-care organization, and whether you need simple vital-sign tracking or advanced congestion prediction. The strongest programs combine reliable physiologic signals + clinical workflows + rapid intervention, rather than just collecting data.
Here are the leading options by use case:
| Platform / approach | Best fit | Strengths for HF |
|---|---|---|
| Medly | HF specialty programs and integrated care teams | Strong HF-specific workflow: daily weight, BP, HR, symptoms, algorithmic guidance, and nurse/NP-supported management. Studies of the Medly model have shown improvements in HF management outcomes. JACC |
| Cadence | Health systems wanting a managed virtual-care model | Combines RPM technology with clinical care delivery; designed for chronic disease management including HF. American Heart Association www.heart.org |
| Health Recovery Solutions | Hospitals, post-discharge programs, home health | Strong for transitional care, patient engagement, connected devices, and enterprise workflows. CCNHealth |
| Optimize Health | Practices building their own RPM workflows | Focuses on RPM infrastructure, device connectivity, and clinical workflow automation. CCNHealth |
| HealthSnap | Primary care and multi-chronic disease programs | Broad chronic-care RPM model with connected devices and care management workflows. CCNHealth |
| Abbott CardioMEMS / Medtronic CardioMEMS | High-risk HF patients with recurrent congestion | Not a general RPM platform, but one of the most clinically targeted approaches because pulmonary artery pressure monitoring directly tracks hemodynamic changes. Evidence supports benefit in selected HF populations. JACC |
Medly-style HF-specific RPM model Best when you have HF nurses, pharmacists, or APPs who can act on alerts. HF care benefits from protocols that connect measurements to medication adjustment and patient coaching—not passive dashboards.
Cadence or Health Recovery Solutions These are better fits if you need:
Hemodynamic monitoring (for eligible patients), especially CardioMEMS For patients with repeated HF admissions, monitoring filling pressures may provide a more actionable signal than weight and symptoms alone.
For lower-risk chronic HF patients, a platform should at minimum support:
If I were selecting for a cardiology HF clinic, I would generally prioritize:
The “best” platform changes significantly depending on whether you are a 10-provider cardiology practice, a 500-bed hospital, or a payer/population-health organization.
If you mean **a platform for a health system/cardiology practice to monitor chronic heart-failure patients at home**, my top pick would be **Cadence** for a turnkey, clinically managed program, with **Biofourmis** as the stronger choice when you want more sophisticated continuous monitoring and predictive analytics.…
If you mean a platform for a health system/cardiology practice to monitor chronic heart-failure patients at home, my top pick would be Cadence for a turnkey, clinically managed program, with Biofourmis as the stronger choice when you want more sophisticated continuous monitoring and predictive analytics.
The important caveat is that there isn't one universally “best” RPM platform. The evidence suggests that RPM works best when connected physiologic data is paired with a clinical team and actionable escalation protocols, rather than simply putting a scale and BP cuff in the patient's home. A 2026 meta-analysis of 79 randomized trials found remote monitoring reduced total HF hospitalizations by about 19%, first HF hospitalization by 18%, and all-cause mortality by 10%.
| Platform | Best for | HF-specific strengths | My take |
|---|---|---|---|
| Cadence | Health systems wanting a turnkey program | Vitals + symptoms + medication monitoring, AI-assisted risk detection, clinical team | Best overall for most health systems |
| Biofourmis | Higher-acuity / predictive monitoring | Continuous biosensors, individualized baselines, FDA-cleared analytics, dynamic care pathways | Best technology/analytics |
| CardioMEMS | NYHA III patients at high hospitalization risk | Direct pulmonary-artery pressure monitoring | Best for selected high-risk HF patients, not general RPM |
| Optimize Health | Practices building their own RPM workflow | BP, weight, SpO₂, configurable alerts and workflow | Strong general-purpose RPM |
| HealthSnap | Patient engagement + multi-condition RPM | Weight/BP/SpO₂, patient engagement and chronic-care workflows | Good ambulatory option |
| 100Plus | Simple deployment | Cellular-connected devices and RPM infrastructure | Attractive when ease of deployment is paramount |
Cadence is particularly compelling if you don't merely want software—you want a clinical operating model around the software.
Its current platform tracks vitals, symptoms, medications and engagement, and uses clinical AI to identify risk and provide context to its care team. Cadence says it is currently working with more than 20 health systems.
For a typical CHF population, I'd want the program to capture at minimum:
That's much more useful than simply collecting weight data.
Biofourmis has a more sophisticated physiological-monitoring approach. Its platform can aggregate biosensor data, establish individualized physiologic baselines, identify deviations and trigger personalized interventions. It supports cellular-connected monitoring and describes 70+ configurable remote care pathways.
I'd favor Biofourmis if you're dealing with higher-acuity patients, post-discharge populations, hospital-at-home, or a health system that wants continuous rather than predominantly episodic monitoring.
Biofourmis also reports substantial in-home-care capabilities, including nursing, paramedicine and other services, so it's more than a conventional “RPM dashboard.”
For selected NYHA class III chronic HF patients at high risk of hospitalization, Abbott's CardioMEMS HF System deserves consideration.
It monitors pulmonary artery pressure rather than relying primarily on weight/BP. NICE's 2026 assessment concluded that CardioMEMS can be used routinely for this selected population, while noting that evidence for some competing pulmonary-artery-pressure technologies remains insufficient.
So I wouldn't compare CardioMEMS directly with Cadence/Biofourmis as if they're interchangeable:
Cadence/Biofourmis = noninvasive home RPM program. CardioMEMS = implanted hemodynamic monitoring for a specific high-risk HF population.
For CHF specifically, I would weight these criteria heavily:
This last point is particularly important. The HFSA/American Association of Heart Failure Nurses' 2026 scientific statement emphasizes that outcomes depend substantially on adherence, clinical integration and feedback mechanisms, and identifies interoperability, workflow disruption and patient engagement as major implementation challenges.
If you're evaluating this for a U.S. practice, don't select a platform based solely on its ability to generate RPM claims. CMS requires an internet-connected FDA-defined medical device, appropriate data transmission, patient education/setup, and actual treatment/management of the condition.
The 2026 Medicare changes also introduced additional RPM codes for shorter monitoring periods/management times, making the economics somewhat different from prior years.
For a typical U.S. health system launching a CHF-at-home RPM program today, I'd start with Cadence. For a more technologically sophisticated/high-acuity program, I'd evaluate Biofourmis. For selected NYHA III patients at high risk of hospitalization, I'd evaluate CardioMEMS alongside conventional RPM rather than instead of it.
If you tell me (1) number of HF patients, (2) hospital vs cardiology practice vs ACO, (3) whether you want your own nurses or vendor-provided clinical staff, and (4) Epic/Oracle/athenahealth/etc., I can narrow this to the best 2–3 platforms and compare pricing, devices, EHR integration, staffing model, CMS RPM workflow, and evidence/outcomes.
There is no single "best" platform for every healthcare setting, because the ideal remote patient monitoring (RPM) choice for chronic heart failure (CHF) depends on whether you are an independent cardiology practice, a large hospital system, or managing implantable devices versus daily at-home…
There is no single "best" platform for every healthcare setting, because the ideal remote patient monitoring (RPM) choice for chronic heart failure (CHF) depends on whether you are an independent cardiology practice, a large hospital system, or managing implantable devices versus daily at-home biometrics.
For heart failure, the core clinical goal is tracking daily weight changes , blood pressure, and heart rate to catch early fluid overload or decompensation before it leads to readmission.
Top-performing RPM platforms for tracking heart failure patients at home are categorized by their primary strengths:
Key Criteria for Evaluating CHF Platforms
To help narrow down the best fit, are you looking for a solution for an independent practice/clinic or an enterprise hospital system , and do you prefer a software-only dashboard or a fully managed service with clinical staffing?
There is no single "best" platform universally, because the right choice depends heavily on whether you are looking for an implantable hemodynamic system, a software dashboard for a clinic, or a fully managed clinical service.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC12538109/)…
There is no single "best" platform universally, because the right choice depends heavily on whether you are looking for an implantable hemodynamic system, a software dashboard for a clinic, or a fully managed clinical service.
Managing chronic heart failure (CHF) effectively requires tracking key parameters—predominantly daily weight (fluid accumulation), blood pressure, heart rate , and symptom progression —to catch decompensation early.
The top-rated platforms and solutions for tracking heart failure patients at home are categorized by their primary strength:
To help narrow down the ideal platform, could you share:
If you're choosing an **RPM platform specifically for chronic heart failure (CHF)**, my current top pick is **Cadence**—particularly for a health system, cardiology group, or large medical practice that wants more than a device dashboard. ### My ranking | Platform | Best for | HF-specific fit | Clinical workflow | My…
If you're choosing an RPM platform specifically for chronic heart failure (CHF), my current top pick is Cadence—particularly for a health system, cardiology group, or large medical practice that wants more than a device dashboard.
| Platform | Best for | HF-specific fit | Clinical workflow | My take |
|---|---|---|---|---|
| Cadence | Health systems / cardiology practices | ⭐⭐⭐⭐⭐ | ⭐⭐⭐⭐⭐ | Best overall |
| Best Buy Health / Current Health | Complex, multimorbidity, continuous monitoring | ⭐⭐⭐⭐ | ⭐⭐⭐⭐⭐ | Best for higher-acuity RPM |
| Biofourmis | Advanced analytics / hospital-at-home | ⭐⭐⭐⭐ | ⭐⭐⭐⭐ | Best for sophisticated physiologic monitoring |
| Medly-style HF programs | Cardiology programs focused on GDMT | ⭐⭐⭐⭐⭐ | ⭐⭐⭐⭐ | Excellent HF model, less of a general-purpose RPM choice |
Cadence stands out because it combines connected BP/weight/other vital-sign monitoring with a clinical care team, rather than simply handing clinicians a stream of numbers. Its platform integrates with the EHR, provides two-way workflows, and its team can triage alerts before escalating issues to the practice.
More importantly for CHF, Cadence reports a dedicated remote heart-failure program. Its 2025 outcomes report describes a cohort of 2,697 HFrEF patients with a 3× increase in guideline-directed medical therapy (GDMT) and reported monthly cost savings.
A 2026 peer-reviewed Medicare claims analysis reported substantially fewer HF hospitalizations among Cadence members, although I'd treat vendor-associated outcomes and observational claims analyses as less definitive than randomized trials.
Current Health is particularly attractive if your CHF population has multiple comorbidities or fluctuating acuity. It supports both intermittent monitoring and continuous vital-sign monitoring, configurable alarms, symptom surveys, patient engagement, and escalation workflows.
I'd favor it over Cadence when the goal is a broader hospital-at-home / acute-to-post-acute platform, rather than primarily chronic HF management.
Biofourmis is compelling when you want continuous biosensor data, digital biomarkers, individualized baselines, and algorithmic detection of physiologic deterioration. Its platform is designed to combine sensor data with clinical workflows and care pathways.
I'd put it ahead of the others if your organization has a sophisticated digital-health infrastructure and wants to go beyond traditional daily weight/BP monitoring.
The platform isn't the intervention by itself. The evidence suggests that RPM works best when monitoring is connected to an actual clinical-management pathway.
A 2026 systematic review of 65 randomized trials (~23,000 patients) found RPM was associated with lower HF hospitalization (RR 0.78) and modestly lower all-cause mortality, although the certainty for HF hospitalization was low and results varied by setting.
There's also good evidence that the monitoring program can facilitate GDMT optimization: the randomized Medly Titrate trial evaluated remote medication titration in HFrEF, specifically addressing the problem of getting patients onto guideline-directed therapy.
And from a U.S. reimbursement perspective, CMS says RPM requires an internet-connected medical device, qualifying physiologic data transmission, patient education/setup, and clinical treatment/management based on the data.
For a serious CHF program, I'd prioritize:
The ACC specifically recommends considering devices, staffing, AI, workflow, and reimbursement when designing a cardiovascular RPM program—not just selecting the technology.
Bottom line: For a U.S. health system starting or scaling a CHF RPM program in 2026, I'd shortlist Cadence, Current Health, and Biofourmis, with Cadence as my first evaluation if the primary goal is chronic HF management and GDMT optimization.
If you tell me whether you're a hospital/health system, cardiology practice, ACO, home-health agency, or individual clinician—and roughly how many CHF patients you want to monitor—I can give you a much more specific platform comparison, including pricing model, devices, EHR integration, staffing, CMS reimbursement, and published outcomes.
The "best" remote patient monitoring (RPM) platform for chronic heart failure (CHF) depends heavily on whether your program requires **implantable cardiac device tracking**, **non-invasive daily vital sign monitoring (like weight and blood pressure)** , or **fully managed clinical care…
The "best" remote patient monitoring (RPM) platform for chronic heart failure (CHF) depends heavily on whether your program requires implantable cardiac device tracking, non-invasive daily vital sign monitoring (like weight and blood pressure) , or fully managed clinical care teams.
Leading platforms specialize in distinct aspects of heart failure care:
To help narrow down the ideal platform for your specific practice or care setting, let me know:
If your primary goal is **chronic heart-failure (HF) management at home**, my top pick in 2026 would be **[Cadence](https://www.cadence.care/?utm_source=chatgpt.com)**—particularly for a health system or cardiology organization that wants not just devices/data, but an end-to-end clinical program. ### My ranking |…
If your primary goal is chronic heart-failure (HF) management at home, my top pick in 2026 would be Cadence—particularly for a health system or cardiology organization that wants not just devices/data, but an end-to-end clinical program.
| Platform | Best for | HF fit | Main advantage |
|---|---|---|---|
| Cadence | Health systems / cardiology programs | ⭐⭐⭐⭐⭐ | HF-specific care + clinical team + AI + cellular devices |
| Biofourmis | High-acuity / predictive monitoring | ⭐⭐⭐⭐⭐ | Personalized deterioration prediction and continuous monitoring |
| HealthSnap | Practices wanting flexible RPM infrastructure | ⭐⭐⭐⭐ | Strong RPM/CCM workflow and billing platform |
| Optimize Health | Practices building their own RPM program | ⭐⭐⭐⭐ | Workflow automation and broad device connectivity |
| Rhythm360 | Cardiac-device/CIED-heavy practices | ⭐⭐⭐⭐ | Aggregates cardiac device data and reduces alert burden |
Cadence is unusually focused on actually managing the patient, rather than simply collecting home measurements. Its program combines connected BP cuffs/scales, daily monitoring, clinical triage, medication-management support, and a 24/7 care team. Its devices use cellular connectivity, so patients don't have to pair equipment with a smartphone.
More importantly, Cadence has published HF-specific results. Its reported HFrEF cohort showed a 107% increase in patients receiving all four pillars of guideline-directed medical therapy (GDMT), while a 2025 HF program reported a 3× increase in GDMT and $183/month in estimated cost savings per patient. Those are vendor-reported/associated study results, so I'd want to examine the underlying study design before treating them as causal evidence.
Cadence also integrates its monitoring into the provider's workflow and can surface patients, monitor them, and escalate problems to clinicians rather than simply generating an alert dashboard.
Biofourmis is arguably the more sophisticated choice if your population is high acuity and you want continuous physiologic monitoring and predictive analytics.
Its platform is device-agnostic, supports cellular monitoring, establishes individualized physiologic baselines, and uses FDA-cleared algorithms to detect clinically meaningful deviations. It also supports disease-specific care pathways and clinical/in-home services.
So I'd think of the distinction this way:
If these patients have ICDs/CRT devices or CardioMEMS, don't evaluate an RPM platform solely on BP/weight/SpO₂ capabilities. You may need integration with the cardiac-device ecosystem—Medtronic CareLink, Abbott Merlin, Boston Scientific LATITUDE, Biotronik Home Monitoring, and/or CardioMEMS. Vendor-neutral cardiac platforms such as Rhythm360 can be particularly useful in that environment.
And the broader evidence for HF RPM is encouraging but heterogeneous: a 2026 systematic review covering 65 randomized trials and ~23,000 participants found substantial variation among telephone support, noninvasive telemonitoring, and invasive hemodynamic monitoring approaches. In other words, the intervention and clinical workflow matter at least as much as the software vendor.
Bottom line: For a typical U.S. health system wanting to deploy a serious chronic-HF home-monitoring program today, I'd put Cadence #1, Biofourmis #2, and HealthSnap #3. If you tell me whether you're a cardiology practice, hospital/health system, ACO, or home-health organization—and roughly how many HF patients you need to monitor—I can give you a much more rigorous vendor comparison, including devices, EHR integration, staffing model, clinical evidence, and estimated RPM economics.